EndGenitor Technologies

EndGenitor Technologies, Inc. (EGT), established in 2005, is a privately held company headquartered in Indianapolis, USA. The company aims to develop novel adult stem cell therapies, which are currently in the preclinical development stage, focusing on cardiovascular, hematology, and related therapeutic indications. EndGenitor also markets adult stem cell products to the research market through its distribution partner, Dynacell Life Sciences, LLC.